相关实验视频
Updated: Jun 26, 2025

06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
101
当传统的救援疗法在急性严重性结肠炎中失败时,该怎么做?
Christopher F D Li Wai Suen1,2, Matthew C Choy1,2, Peter De Cruz1,2
1Department of Gastroenterology, Austin Health, Melbourne, Australia.
Intestinal research
|May 15, 2024
概括
急性严重性结肠炎 (ASUC) 是一种严重的疾病,需要紧急治疗. 本综述涵盖了对标准疗法不反应的患者的现代管理策略,包括生物药物和JAK抑制剂.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床治疗学 临床治疗学
背景情况:
- 急性严重性结肠炎 (ASUC) 影响了25%的性结肠炎患者.
- 结果是可变的,对皮质类固醇和救援疗法的不响应率很高.
- 在高达50%的不响应患者中,需要紧急切除肠道.
研究的目的:
- 审查ASUC.的当代临床管理方法.
- 专注于针对那些无法通过传统救援疗法治疗的患者的策略.
- 纳入有关先进治疗选择的新兴数据.
主要方法:
- 对当前ASUC管理的文献综述.
- 对因弗力西马布剂量新出现的数据的分析.
- 评估环素作为桥梁疗法.
- 在ASUC中对Janus激酶 (JAK) 抑制的评估.
主要成果:
- 皮质类固醇和救援疗法 (infliximab,cyclosporin) 的失败率显著.
- 目前正在为非响应患者开发新的治疗策略.
- 优化的INFLIXIMAB剂量和JAK抑制显示出有前途的结果.
结论:
- 有效管理ASUC需要针对非响应者量身定制的方法.
- 像JAK抑制剂这样的先进疗法提供了新的治疗途径.
- 对最佳测序和剂量进行进一步的研究至关重要.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
136
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
136
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331

